District-randomized phased implementation: Strengthening the evidence base for cotrimoxazole for HIV-positive tuberculosis patients

AIDS

Volumn 17, Issue 7, 2003, Pages 1079-1081

  Godfrey Faussett, Peter ^a,b  

^a HOSPITAL FOR TROPICAL DISEASES   (United Kingdom)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

Cotrimoxazole; HIV; Sub Saharan Africa; Tuberculosis; Voluntary counselling and HIV testing

Indexed keywords

ANTIVIRUS AGENT; COTRIMOXAZOLE; ISONIAZID; PLACEBO; RIFAMPICIN; SULFONAMIDE; TUBERCULOSTATIC AGENT;

AFRICA; ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC RESISTANCE; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COTE D'IVOIRE; DRUG EFFICACY; DYSENTERY; EVIDENCE BASED MEDICINE; GOVERNMENT; HEALTH CARE POLICY; HEALTH PROGRAM; HEALTH SURVEY; HOSPITALIZATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LABORATORY TEST; LUNG TUBERCULOSIS; LYMPHOCYTE COUNT; MALARIA; MALAWI; MORBIDITY; MORTALITY; NONHUMAN; PATIENT COUNSELING; PNEUMOCYSTIS PNEUMONIA; PRIMARY PREVENTION; PRIORITY JOURNAL; PUBLICATION; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; REVIEW; SECONDARY PREVENTION; SPUTUM SMEAR; TREATMENT INDICATION; TREATMENT OUTCOME; WORLD HEALTH ORGANIZATION;

AFRICA; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTI-INFECTIVE AGENTS; EVIDENCE-BASED MEDICINE; HUMANS; RANDOMIZED CONTROLLED TRIALS; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION; TUBERCULOSIS;

EID: 0038555476     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200305020-00019     Document Type: Review

References (15)

1. Fox W, Ellard GA, Mitchison DA. Studies on the treatment of tuberculosis undertaken by the British Medical Research Council tuberculosis units, 1946-1986, with relevant subsequent publications. Int J Tuberc Lung Dis 1999, 3(10 Suppl 2):S231-S279.
2. Osmond, D, Charlebois E, Lang W, Shiboski S, Moss A, Nyangulu D, Veen J, Ringdal T. Changes in AIDS survival time in two San Francisco cohorts of homosexual men, 1983 to 1993. JAMA 1994, 271:1083-1087.
3. Grant AD, Djomand G, De Cock KM. Natural history and spectrum of disease in adults with HIV/AIDS in Africa. AIDS 1997, 11(Suppl B):S43-S54.
4. Lucas SB, Hounnou A, Peacock C, Beaumel A, Djomand G, N'gbichi J-M, et al. The mortality and pathology of HIV infection in a west African city. AIDS 1993, 7:1569-1579.
5. Hargreaves NJ, Kadzakumanja O, Phiri S, Lee CH, Tang X, Salaniponi FM, et al. Pneumocystis carinii pneumonia in patients being registered for smear-negative pulmonary tuberculosis in Malawi. Trans R Soc Trop Med Hyg 2001, 95:402-408.
6. Wiktor SZ, Sassan-Morokro M, Grant AD, Abouya L, Karon JM, Maurice C, et al. Efficacy of trimethoprim-sulphamethoxazole prophylaxis to decrease morbidity and mortality in HIV-1-infected patients with tuberculosis in Abldjan, Cote d'lvoire: a randomised controlled trial. Lancet 1999, 353:1469-1475.
7. Anglaret X, Chene G, Attia A, Ture S, Lafont S, Combe S, et al. Early chemoprophylaxis with trimethoprim-sulphamethoxazole for HIV-1-infected adults in Abidjan, Cote d'lvoire: a randomised trial. Cotrimo-Cl Study Group. Lancet 1999, 353:1463-1468.
8. UNAIDS. Provisional WHO/UNAIDS Secretariat Recommendations on the use of Cotrimoxazole Prophylaxis in Adults and Children Living with HIV/AIDS in Africa. Geneva: WHO/UNAIDS; 2000.
9. Maynart M, Lievre L, Sow PS, Badiane S, Coulaud JP, Delaporte E, et al. Primary prevention with cotrimoxazole for HIV-1-infected adults: results of the pilot study in Dakar, Senegal. J Acquir Immune Defic Syndr 2001, 26:130-136.
10. Mwansa J, Mutela K, Zulu I, Amadi B, Kelly P, Antimicrobial sensitivity in enterobacteria from AIDS patients, Zambia. Emerg Infect Dis 2002, 8:92-93.
11. MacArthur J, Stennies GM, Macheso A, Kolczak MS, Green MD, Ali D, et al. Efficacy of mefloquine and sulfadoxine-pyrimethamine for the treatment of uncomplicated Plasmodium falciparum infection in Machinga District, Malawi, 1998. Am J Trop Med Hyg 2001, 65:679-684.
12. Zachariah R, Spielmann MPL, Chinji C, Gomani P, Arendt V, Hargreaves NJ, et al. Voluntary counselling, HIV testing and adjunctive cotrimoxazole reduces mortality in tuberculosis patients in Thyolo, Malawi. AIDS 2003, 17:LWW to complete at revises.
13. Harries AD, Mbewe LNO, Salaniponi FML, Nyangulu D, Veen J, Ringdal T, et al. Tuberculosis programme changes and treatment outcomes in patients with smear-positive pulmonary tuberculosis in Blantyre, Malawi. Lancet 1996, 347:807-809.
14. Nunn P, Brindle R, Carpenter L, Odhiambo J, Wasunna K, Newnham R, et al. Cohort study of human immunodeficiency virus infection in patients with tuberculosis in Nairobl, Kenya. Analysis of early (6-month) mortality. Am Rev Respir Dis 1992, 146:849-854.
15. An expanded DOTS framework for effective tuberculosis control. Int J Tuberc Lung Dis 2002, 6:378-388.